Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Universal cancer peptides derived from telomerase

Universal cancer peptides derived from telomerase

US Patent 9669080 · Granted Jun 6, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors against multiple HLA-G isoforms2025
Telomerase encoding DNA vaccine2024
Anti HLA-G specific antibodies2023
Chimeric antigen receptors against multiple HLA-G isoforms2022
Recombinant measles vaccine expressing hTERT2022
Chimeric antigen receptors against multiple HLA-G isoforms2022
Anti HLA-G specific antibodies2022
Chimeric antigen receptors against multiple HLA-G isoforms2021
Anti HLA-G specific antibodies2021
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereo2020
Universal cancer peptides derived from telomerase2020
Universal cancer peptides derived from telomerase2020